WallStreetZenWallStreetZen

NASDAQ: INO
Inovio Pharmaceuticals Inc Stock Ownership - Who owns Inovio Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Inovio Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael John SumnerChief Medical Officer2025-05-15680$1.95
$1.33kSell
Laurent HumeauChief Scientific Officer2025-05-151,708$1.95
$3.33kSell
Peter KiesCFO2025-05-152,566$1.95
$5.00kSell
Jacqueline Elizabeth SheaChief Executive Officer2025-05-157,717$1.95
$15.05kSell
Jacqueline Elizabeth SheaChief Executive Officer2025-05-102,392$1.80
$4.31kSell
Laurent HumeauChief Scientific Officer2025-02-261,584$1.98
$3.14kSell
Jacqueline Elizabeth SheaChief Executive Officer2025-02-262,493$1.98
$4.94kSell
Peter KiesCFO2025-02-262,960$1.98
$5.86kSell
Laurent HumeauChief Scientific Officer2025-02-262,059$1.98
$4.08kSell
Peter KiesCFO2025-02-262,362$1.98
$4.68kSell

1 of 2

INO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INO insiders and whales buy or sell their stock.

INO Shareholders

What type of owners hold Inovio Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Austin W. Greenhouse David M. Marxe38.86%20,650,987$57.62MInsider
Tee Khiang Ng9.22%4,899,931$13.67MInsider
Jong Joseph Kim4.41%2,346,000$6.55MInsider
Vanguard Group Inc3.78%2,009,145$5.61MInstitution
Deep Track Capital LP3.73%1,981,370$5.53MInstitution
Bank Of America Corp2.39%1,270,607$3.54MInstitution
Beng Lee Gan1.55%823,045$2.30MInsider
Kevin Rassas1.37%726,088$2.03MInsider
Blackrock Inc1.01%537,628$1.50MInstitution
Geode Capital Management LLC0.82%437,549$1.22MInstitution

1 of 3

INO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INO19.13%58.44%Net Selling
GLSI8.64%91.36%Net Buying
ACOG35.39%5.20%Net BuyingNet Buying
NKTX62.30%37.70%Net SellingNet Selling
ELDN57.27%42.73%
View Top Biotech Stocks

Inovio Pharmaceuticals Stock Ownership FAQ

Who owns Inovio Pharmaceuticals?

Inovio Pharmaceuticals (NASDAQ: INO) is owned by 19.13% institutional shareholders, 58.44% Inovio Pharmaceuticals insiders, and 22.43% retail investors. Austin W. Greenhouse David M. Marxe is the largest individual Inovio Pharmaceuticals shareholder, owning 20.65M shares representing 38.86% of the company. Austin W. Greenhouse David M. Marxe's Inovio Pharmaceuticals shares are currently valued at $59.27M.

If you're new to stock investing, here's how to buy Inovio Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.